Bulgaria's Sopharma buys back 66,000 own shares
Adris, Koncar, Podravka boost Croatia’s share indices
Bulgaria's TPP Bobov Dol 9-mo cons net profit surges 142% y/y
Romanian stock indices start week in the green, Sphera shines
Romania eyes over 8 GW installed PV capacity by 2030 - president
Nov 08, 2017 17:07 EEST
November 8 (SeeNews) - Luxembourg-based company Aelius has paid to the Serbian government the 16 million euro ($18.5 million) it offered for the purchase of the state-owned 93.7% stake in ailing drug maker Galenika, Belgrade-based media reported on Wednesday.
Aelius is expected to repay by the end of the week Galenika's 25 million euro debt plus a compensation worth 200 euro per every year with the company to the employees who joined is voluntary downsizing plan, news agency Tanjug reported.
You can subscribe to our M&A newsletter here
Serbia's economy ministry said earlier this month it signed a contract for the sale of the Galenika stake to Aelius, a company affiliated to Brazilian pharma group EMS SA.
The Serbian government launched a tender for the sale of its stake in Galenika on September 1. The minimum price was set at 25 million euro, to be used for repayment of Galenika debt, plus 1 euro for the tendering.
($ = 0.8628 euro)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options